Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pulmonx Corp (NQ: LUNG )

6.270 +0.020 (+0.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pulmonx Corp

< Previous 1 2 3 4 Next >
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
Analyst Ratings for Pulmonx
Via Benzinga
Expert Ratings for Pulmonx
Via Benzinga
Pulmonx to Present at the Citi 2023 Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx to Report Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
From Pulmonx Corporation
Via GlobeNewswire
PDS Biotechnology, Pulmonx, Tesla And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Why Pulmonx Stock Is Crashing Today
Investors are reacting negatively to the company's planned securities offering. 
Via The Motley Fool
A Look Into Pulmonx's Debt
Shares of Pulmonx Inc. (NASDAQ:LUNG) decreased by 71.09% in the past three months. Before we understand the importance of debt, let's look at how much debt Pulmonx has. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Where Pulmonx Stands With Analysts
Within the last quarter, Pulmonx (NASDAQ:LUNG) has observed the following analyst ratings: 
Via Benzinga
American Lung Association Campaign Shines Spotlight on Endobronchial Valves for Advanced COPD/Emphysema
From Pulmonx Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
From Pulmonx Corporation
Via Business Wire
How Is The Market Feeling About Pulmonx?
Pulmonx's (NASDAQ:LUNG) short percent of float has fallen 12.87% since its last report. The company recently reported that it has 3.25 million shares sold short, which is 10.97% of all regular shares... 
Via Benzinga
Pulmonx to Present at the 34th Annual Piper Sandler Healthcare Conference
From Pulmonx Corporation
Via GlobeNewswire
Dow Rises 100 Points; Silver Jumps 7%
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining over 100 points on Friday. 
Via Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
Gainers 
Via Benzinga
Peering Into Pulmonx's Recent Short Interest
Pulmonx's (NASDAQ:LUNG) short percent of float has risen 6.88% since its last report. The company recently reported that it has 3.73 million shares sold short, which is 12.59% of all regular shares... 
Via Benzinga
Nasdaq Turns Lower; Crude Oil Rises Sharply
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Friday. 
Via Benzinga
Dow Surges 150 Points; US Economy Adds 261,000 Jobs
U.S. stocks traded higher this morning, following the release of jobs data for the month of October. 
Via Benzinga
Pulmonx to Participate at Upcoming Investor Conferences
From Pulmonx Corporation
Via GlobeNewswire
Pulmonx Reports Third Quarter 2022 Financial Results
From Pulmonx Corporation
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
  During Monday's session, 96 stocks hit new 52-week lows. 
Via Benzinga
Pulmonx to Report Third Quarter 2022 Financial Results on November 3, 2022
From Pulmonx Corporation
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
  During Friday, 125 stocks hit new 52-week lows. 
Via Benzinga
ADDING and REPLACING CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema
From Pulmonx Corporation
Via Business Wire
Pulmonx to Present at Upcoming September Investor Conferences
From Pulmonx Corporation
Via Business Wire
Pulmonx: Q2 Earnings Insights
Pulmonx (NASDAQ:LUNG) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Pulmonx beat estimated earnings by... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.